Funding opportunities symptoms and conditions

My opinion:

After many hours of searching scientific databases, I have so far been unable to find any research that has been done on how Singulair (montelukast) affects the brain and brain function. So far, I have also found no funding opportunities for any researchers to study montelukast and the brain. That does not mean that they don't exist, I just haven't located any as of today. I have been to many sites putting montelukast in the search area.

I personally believe that this is a consumer BEWARE situation. I personally would not take this drug after seeing for myself how little we can find out about how it interacts with brain chemicals. The FDA needs to require drug companies to study how medications affect the entire body not just one area. Human beings aren't just a nose and a pair of lungs. And we can't keep going around to different doctors to try to find a fix for a medication that is screwing up other parts of our bodies.

After learning that some researchers in other countries have found leukoteine receptors in the brain of human beings, I find it possible to believe that everyone who takes this medication that suppresses the function of those receptors are in some way being affected by Singulair whether they know it or not. I would want to know that Singulair was studied carefully to show how it affects the brain and what the long term consequences are for those who take it. Until that is done, I believe that consumers should heed the warnings regarding adverse psychiatric drug reactions and consider all of the potential options for safe and effective treatment of their conditions. If Singulair is the best option, then consumers should be told what the risk are and how to handle them.

If any one is following what research is being done, here is the description of the new study in children.

http://clinicaltrials.gov/ct2/show/NCT00540839?intr=%22Montelukast%22&rank=19